Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB) Share Price

Price 985.00p on 25-06-2025 at 17:55:07
Change 0.00p 0%
Buy 1,010.00p
Sell 960.00p
Buy / Sell 4BB Shares
Last Trade: Buy 160.00 at 994.00p
Day's Volume: 282
Last Close: 985.00p
Open: 985.00p
ISIN: GB00BMCLYF79
Day's Range 985.00p - 985.00p
52wk Range: 940.00p - 1,600.00p
Market Capitalisation: £152m
VWAP: 982.60638p
Shares in Issue: 15m

4basebio Plc (4BB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 160 994.00p Ordinary
14:05:38 - 25-Jun-25
Sell* 9 967.00p Ordinary
12:02:29 - 25-Jun-25
Sell* 110 967.00p Ordinary
12:01:03 - 25-Jun-25
Unknown* 0 960.00p SI Trade
11:45:51 - 25-Jun-25
Buy* 3 994.00p Ordinary
08:31:12 - 25-Jun-25
Sell* 341 967.00p Ordinary
10:33:02 - 23-Jun-25
Buy* 70 1,000.00p Ordinary
12:29:52 - 19-Jun-25
Sell* 3 962.00p Ordinary
10:47:52 - 19-Jun-25
Buy* 10 1,007.50p Ordinary
10:03:47 - 18-Jun-25
Buy* 4 1,007.50p Ordinary
10:03:15 - 18-Jun-25
See more 4basebio Plc trades

4basebio Plc (4BB) Share Price History

Time period:
to
Date Open High Low Close Volume
24th Jun 2025 (Tue) 985.00 940.00 940.00 985.00 3
23rd Jun 2025 (Mon) 985.00 985.00 985.00 985.00 341
20th Jun 2025 (Fri) 985.00 985.00 985.00 985.00 0
19th Jun 2025 (Thu) 985.00 985.00 985.00 985.00 73
18th Jun 2025 (Wed) 985.00 985.00 985.00 985.00 14
17th Jun 2025 (Tue) 985.00 985.00 985.00 985.00 811
16th Jun 2025 (Mon) 985.00 985.00 985.00 985.00 3,690
13th Jun 2025 (Fri) 1,070.00 1,070.00 985.00 985.00 4,674
12th Jun 2025 (Thu) 1,070.00 1,070.00 1,070.00 1,070.00 938
11th Jun 2025 (Wed) 1,070.00 1,070.00 1,070.00 1,070.00 1
10th Jun 2025 (Tue) 1,070.00 1,070.00 1,070.00 1,070.00 2,337
9th Jun 2025 (Mon) 1,110.00 1,110.00 1,070.00 1,070.00 1,849
6th Jun 2025 (Fri) 1,110.00 1,110.00 1,110.00 1,110.00 0
5th Jun 2025 (Thu) 1,110.00 1,110.00 1,110.00 1,110.00 1,160
4th Jun 2025 (Wed) 1,110.00 1,110.00 1,110.00 1,110.00 128
3rd Jun 2025 (Tue) 1,110.00 1,110.00 1,110.00 1,110.00 88
2nd Jun 2025 (Mon) 1,110.00 1,110.00 1,110.00 1,110.00 388
30th May 2025 (Fri) 1,110.00 1,110.00 1,110.00 1,110.00 108
29th May 2025 (Thu) 1,110.00 1,110.00 1,070.00 1,110.00 7
28th May 2025 (Wed) 1,110.00 1,110.00 1,110.00 1,110.00 1
27th May 2025 (Tue) 1,125.00 1,110.00 1,070.00 1,110.00 272
26th May 2025 (Mon) 1,100.50 1,100.50 1,100.50 1,100.50 0
See more 4basebio Plc price history

4basebio Plc (4BB) Regulatory News

Date Source Headline
17th Jun 2025 7:00 am PRN Holding(s) in Company
17th Jun 2025 7:00 am PRN Holding(s) in Company
27th May 2025 7:00 am PRN Final Results and Notice of AGM
4th Apr 2025 12:00 pm PRN Director Dealing
2nd Apr 2025 7:00 am PRN 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility
25th Mar 2025 10:15 am PRN Holding(s) in Company
14th Mar 2025 7:00 am PRN RBC Capital Markets initiates research coverage
7th Mar 2025 7:00 am PRN Employee Long Term Incentive Plan and Issue of Equity
3rd Mar 2025 4:37 pm PRN Director's Dealing
8th Jan 2025 7:00 am PRN Appointment of Chief Commercial Officer
See more 4basebio Plc regulatory news

4basebio Plc (4BB) Share News

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

4basebio expects to sustain DNA sales growth momentum in 2025

27th May 2025 11:57

(Alliance News) - 4basebio on Tuesday reported a wider pretax loss in 2024, despite higher revenue, and said it is optimistic about the year to come. Read More

IN BRIEF: 4basebio hits "critical milestone" as it secures GMP licence

2nd Apr 2025 09:51

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Secures good manufacturing practice, or GMP, certification for its UK DNA manufacturing facility from the UK Medicines & Healthcare Products Regulatory Agency. This authorises it to manufacture and supply investigational medicinal product drug substance and critical starting biological medicinal materials used in advanced therapy medicinal products from its Cambridge facility, says the firm. Adds that the certification strengthens its position in the advanced therapeutics field and progresses it towards commercialisation and patient care for a range of advanced therapies. Chief Executive Heikki Lanckriet says: "Achieving GMP certification is a critical milestone for 4basebio, validates our ability to supply synthetic DNA for clinical applications and underscores the hard work and innovation of our team and sets the stage for the next phase of growth for the company." Read More

IN BRIEF: 4basebio names Gabe Longoria as new chief commercial officer

8th Jan 2025 11:47

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Names Gabe Longoria as the new chief commercial officer. Longoria was previously CCO at Astrea Bioseparations Ltd. The appointment follows a GBP40 million investment into 4basebio by Elevate Medical Technologies and M&G Investment Management Ltd, which completed in November. This is a "key milestone" for the company. Read More

IN BRIEF: 4basebio to supply synthetic DNA for mRNA vaccine program

10th Apr 2024 11:21

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Announces the supply of its HQ synthetic DNA to an unnamed "Tier 1 pharma company". Says the client will use the synthetic DNA in late preclinical studies for an mRNA vaccine program. Financial details of the contract were not provided by 4basebio. Read More

See more 4basebio Plc news
FTSE 100 Latest
Value8,718.75
Change-40.24

Login to your account

Forgot Password?

Not Registered